YOLFTbeta
Novocure Ltd

Novocure Ltd

NVCR · NASDAQ · Healthcare / Medical Devices

11.83USD+0.11 (+0.94%)

Price History

Full chart

Market Stats

Previous Close11.72
Open11.70
Day Range11.44 – 11.90
52-Week Range9.82 – 21.45
Volume1.05M
Market Cap1.84B
P/E (TTM)0.00
Forward P/E909.09
EPS-1.30
Dividend Yield0.00%
Beta1.01
50-Day Avg16.76
200-Day Avg14.63

About

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Frank Leonard
  • Employees1.60K
  • HeadquartersNeuhofstrasse 21, Baar, Switzerland, 6340, USA
  • Websitehttps://www.novocure.com

Leadership

  • Mr. William F. DoyleExecutive Chairman · b. 1962
  • Mr. Frank LeonardCEO & Director
  • Mr. Christoph BrackmannChief Financial Officer · b. 1974
  • Mr. Michael PuriChief Human Resources Officer · b. 1969
  • Dr. Uri Weinberg M.D., Ph.D.Chief Innovation Officer & Chief Medical Officer · b. 1978
  • Mr. Mukund ParavasthuChief Operating Officer · b. 1970
  • Mr. Adam DaneyHead of Investor Relations
  • Mr. Barak Ben-AryeGeneral Counsel · b. 1977

Financials

Income Statement

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue10.36M15.49M33.09M82.89M177.03M248.07M351.32M494.37M535.03M537.84M509.34M605.22M655.35M
Growth (%)-+49.53%+113.60%+150.52%+113.57%+40.13%+41.62%+40.72%+8.23%+0.53%-5.30%+18.82%+8.28%
Cost of Revenue7.01M10.04M20.61M46.28M55.61M80.05M88.61M106.50M114.88M114.87M128.28M137.18M166.88M
Gross Profit3.35M5.45M12.48M36.61M121.42M168.02M262.71M387.87M420.15M422.97M381.06M468.04M488.47M
Gross Margin32.30%35.21%37.71%44.16%68.59%67.73%74.78%78.46%78.53%78.64%74.81%77.33%74.54%
Operating Expense67.81M85.61M116.47M151.92M160.75M201.69M263.63M357.46M464.49M512.50M613.93M638.53M642.27M
Operating Income-64.46M-80.16M-104.00M-115.32M-39.33M-33.67M-914.00K30.40M-44.33M-89.52M-232.87M-170.50M-153.80M
Operating Margin-622.25%-517.47%-314.31%-139.12%-22.22%-13.57%-0.26%6.15%-8.29%-16.64%-45.72%-28.17%-23.47%
EBITDA-63.13M-78.19M-100.84M-109.67M-31.65M-24.67M7.55M44.83M-34.08M-78.90M-177.45M-109.58M-119.05M
EBITDA Margin-609.45%-504.80%-304.78%-132.31%-17.88%-9.94%2.15%9.07%-6.37%-14.67%-34.84%-18.11%-18.17%
Net Income-77.37M-80.68M-111.58M-131.84M-61.66M-63.56M-7.23M19.81M-58.35M-92.53M-207.04M-168.63M-136.23M
Net Income Margin-746.89%-520.87%-337.24%-159.06%-34.83%-25.62%-2.06%4.01%-10.91%-17.20%-40.65%-27.86%-20.79%
R&D34.80M40.38M43.75M41.47M38.10M50.57M79.00M132.01M201.30M206.09M223.06M209.65M224.54M
R&D as % of Total Revenue335.91%260.69%132.22%50.03%21.52%20.39%22.49%26.70%37.62%38.32%43.79%34.64%34.26%
Interest Expense12.67M183.00K2.37M5.94M10.26M13.49M13.72M18.05M3.44M3.33M4.91M11.66M17.04M
Interest Expense % of Total Revenue122.29%1.18%7.17%7.16%5.80%5.44%3.90%3.65%0.64%0.62%0.96%1.93%2.60%

Balance Sheet

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets188.91M117.88M307.34M282.08M265.30M339.79M479.45M1.05B1.14B1.19B1.15B1.24B804.33M
Total Liabilities17.13M20.00M56.52M139.74M151.73M227.53M261.66M575.46M729.00M750.48M783.63M880.61M463.86M
Total Equity171.78M97.88M250.82M142.34M113.56M112.26M217.79M476.53M410.49M441.17M362.50M360.18M340.47M
Cash175.89M57.61M119.42M99.78M78.59M140.62M177.32M246.17M208.80M115.33M240.82M163.77M103.39M
Total Debt346.00K321.00K23.10M192.66M194.81M149.27M187.10M450.68M632.22M639.09M596.24M683.35M290.00M
Net Debt-175.55M-57.29M-96.33M-3.55M18.75M8.65M-13.76M204.51M366.41M468.94M355.42M519.59M186.61M

Cash Flow

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-52.72M-74.24M-99.88M-107.59M-33.13M-1.86M26.62M99.15M82.76M30.79M-73.34M-26.37M-49.03M
Investing Cash Flow10.40M-46.18M-115.30M12.81M6.77M-5.49M-51.67M-472.85M-144.83M-139.96M184.15M-140.24M437.28M
Financing Cash Flow183.32M2.15M276.99M75.12M5.17M69.37M61.68M440.21M25.70M15.49M15.79M90.31M-451.34M
Capital Expenditure3.63M2.32M10.27M17.66M7.37M6.71M10.48M14.97M24.17M21.36M27.09M42.85M26.65M
Free Cash Flow-56.34M-76.56M-110.16M-125.26M-40.50M-8.58M16.14M84.18M58.59M9.43M-100.43M-69.22M-75.68M
Dividends Paid--000--------
FCF to OCF106.88%103.12%110.28%116.42%122.23%459.84%60.61%84.90%70.79%30.63%136.94%262.52%154.35%
Dividend Paid to FCF--0.00%0.00%0.00%--------

Earnings

Report DateOct 26, 2015Mar 1, 2016May 9, 2016Jul 28, 2016Nov 2, 2016Feb 23, 2017Apr 27, 2017Jul 27, 2017Oct 26, 2017Feb 22, 2018Apr 26, 2018Jul 26, 2018Oct 25, 2018Feb 28, 2019May 2, 2019Jul 25, 2019Oct 31, 2019Feb 27, 2020Apr 30, 2020Jul 30, 2020Oct 29, 2020Feb 25, 2021Apr 29, 2021Jul 29, 2021Oct 28, 2021Feb 24, 2022Apr 28, 2022Jul 28, 2022Oct 27, 2022Feb 23, 2023May 4, 2023Jul 27, 2023Oct 26, 2023Feb 22, 2024May 2, 2024Jul 25, 2024Oct 30, 2024Feb 27, 2025Apr 24, 2025Jul 24, 2025Oct 30, 2025Feb 26, 2026Apr 30, 2026Jul 23, 2026Oct 29, 2026
EPS Estimate-0.33-0.32-0.32-0.33-0.31-0.39-0.20-0.22-0.14-0.11-0.13-0.16-0.14-0.13-0.15-0.06-0.040.020.020.010.040.120.010.01-0.06-0.10-0.18-0.14-0.26-0.30-0.34-0.50-0.52-0.52-0.42-0.40-0.33-0.36-0.46-0.39-0.42-0.41-0.51-0.30-0.21
EPS Actual-2.09-1.08-0.42-0.40-0.39-0.26-0.21-0.24-0.13-0.12-0.23-0.17-0.13-0.17-0.13-0.010.020.040.040.020.090.04-0.04-0.14-0.13-0.25-0.04-0.23-0.25-0.36-0.50-0.54-0.46-0.45-0.36-0.31-0.28-0.61-0.31-0.36-0.33-0.22-0.62-0.13-
Surprise-534.33%-237.50%-31.25%-21.21%-25.81%33.33%-5.00%-9.09%7.14%-9.09%-76.92%-6.25%7.14%-30.77%13.33%83.33%150.00%100.00%100.00%100.00%125.00%-66.67%-500.00%-1500.00%-116.67%-150.00%77.78%-64.29%3.85%-20.00%-47.06%-8.00%11.54%13.46%14.29%22.50%15.15%-69.44%32.61%7.69%21.43%46.34%-21.57%56.67%-
TimingAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.84B
Enterprise Value1.69B
Trailing P/E0.00
Forward P/E909.09
PEG Ratio-0.47
Price / Sales2.64
Price / Book5.60
EPS-1.30
Book Value2.90
Revenue (TTM)699.19M
Gross Profit (TTM)533.98M
EBITDA-136.39M
Profit Margin-21.25%
Operating Margin-5.75%
Return on Equity-43.22%
Return on Assets-9.26%
Shares Outstanding116.45M
Shares Float96.42M
Beta1.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 7 analystsTarget 27.14
  • Strong Buy
    3
  • Buy
    2
  • Hold
    2

Ownership Breakdown

Institutions
90.72%
Insiders
9.96%
Retail / Other
0.00%

Top Institutional Holders

  • FMR Inc
    17.07M14.66%
  • BlackRock Inc
    13.19M11.33%
  • Soleus Capital Management, L.P.
    9.91M8.51%
  • Vanguard Portfolio Management, LLC
    6.25M5.37%
  • Vanguard Capital Management, LLC
    4.68M4.02%
  • Morgan Stanley - Brokerage Accounts
    4.54M3.90%
  • Wells Fargo & Co
    2.95M2.53%
  • State Street Corp
    2.56M2.20%
  • Geode Capital Management, LLC
    2.51M2.16%
  • Quantinno Capital Management LP
    2.49M2.14%
  • Renaissance Technologies Corp
    1.55M1.33%
  • Point72 Asset Management, L.P.
    1.36M1.17%
  • Jacobs Levy Equity Management, Inc.
    1.33M1.14%

Top Fund Holders

  • Fidelity Growth Company Fund
    5.87M5.04%
  • Vanguard MStar Total Stk Mkt Idx Invest
    3.50M3.00%
  • iShares Russell 2000 ETF
    2.74M2.35%
  • Vanguard Small Cap Index
    2.53M2.17%
  • Fidelity Growth Company K6
    1.74M1.50%
  • Fidelity Series Growth Company
    1.55M1.33%
  • Vanguard MStar Small Cap Growth Indx Inv
    1.45M1.24%